Talphera (TLPH) Asset Utilization Ratio (2012 - 2026)
Talphera (TLPH) posted Asset Utilization Ratio of 0.0 for Q2 2026, up 5.11% on a QoQ basis from 0.0 in Q1 2026, and down 97.95% year-over-year from 0.0 in Q2 2025.
Analysis
Talphera (TLPH) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Talphera has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.0 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 97.95% year-over-year to 0.0 in Q2 2026; TTM through Jun 2026 was 0.0, a 97.95% decrease from a year earlier, with the FY2025 full-year figure at 0.0, changed N/A from the prior year.
- Asset Utilization Ratio was 0.0 for Q2 2026 at Talphera, up from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.05 in Q4 2023, with the low at 0.0 in Q1 2026.
- Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.01 recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio soared 471.92% in 2023, then plunged 97.95% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then jumped by 471.92% to 0.05 in 2023, then plunged by 76.78% to 0.01 in 2024, then tumbled by 92.44% to 0.0 in 2025, then tumbled by 96.21% to 0.0 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2026), 0.0 (Q1 2026), and 0.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 0.00 |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | 0.04 |